Mynd_Logo_2.png
MENU
mynd-menu.png
MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
Mynd Life Sciences
  • Nov 30, 2021

MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

R&D project on psilocybin’s benefits in treating diseases of the brain VANCOUVER, BC, Nov. 30, 2021 /CNW/ – MYND Life Sciences...
MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
Mynd Life Sciences
  • Nov 30, 2021

MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

R&D project on psilocybin’s benefits in treating diseases of the brain VANCOUVER, BC, Nov. 30, 2021 /CNW/ – MYND Life Sciences Inc. ...
MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test
Mynd Life Sciences
  • Nov 22, 2021

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

MYND Diagnostics will be initiating a clinical validation study on the use of its proprietary biomarker testing in Multiple Sclerosis...
1
2
345
6243633205_d7126ef00c_o_edited.jpg
MYND-FUTURE.png
DIAGNOSTICS
INVESTING
SCIENCE

 
CONTACT
NEWS
  • Twitter
  • Instagram
  • LinkedIn
  • Facebook

© Copyright Mynd Life Sciences 2022

Privacy